Can-Fite Reports Positive Rheumatoid Arthritis Treatment Results

– The 12-week Phase IIb study involving 79 patients with active rheumatoid arthritis met all its primary efficacy endpoints. – Can-Fite BioPharma Ltd. (TASE:CFBI; Bulletin Board:CANFY)  reports More...